9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)
Titel:
9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)
Auteur:
Menis, J. Bironzo, P. Radj, G. Greillier, L. Monnet, I. Livi, L. Young, R. Decroisette, C. Cloarec, N. Robinet, G. Schott, R. Califano, R. De Marinis, F. Mauer, M. Pochesci, A. Silva, M. Caramella, C. Dingemans, A-M. Dive, C. Besse, B.